Literature DB >> 24741377

Perspectives on Non-Animal Alternatives for Assessing Sensitization Potential in Allergic Contact Dermatitis.

Nripen S Sharma1, Rohit Jindal1, Bhaskar Mitra1, Serom Lee1, Lulu Li1, Tim J Maguire1, Rene Schloss1, Martin L Yarmush2.   

Abstract

Skin sensitization remains a major environmental and occupational health hazard. Animal models have been used as the gold standard method of choice for estimating chemical sensitization potential. However, a growing international drive and consensus for minimizing animal usage have prompted the development of in vitro methods to assess chemical sensitivity. In this paper, we examine existing approaches including in silico models, cell and tissue based assays for distinguishing between sensitizers and irritants. The in silico approaches that have been discussed include Quantitative Structure Activity Relationships (QSAR) and QSAR based expert models that correlate chemical molecular structure with biological activity and mechanism based read-across models that incorporate compound electrophilicity. The cell and tissue based assays rely on an assortment of mono and co-culture cell systems in conjunction with 3D skin models. Given the complexity of allergen induced immune responses, and the limited ability of existing systems to capture the entire gamut of cellular and molecular events associated with these responses, we also introduce a microfabricated platform that can capture all the key steps involved in allergic contact sensitivity. Finally, we describe the development of an integrated testing strategy comprised of two or three tier systems for evaluating sensitization potential of chemicals.

Entities:  

Keywords:  2D cell based models; 3D skin tissue models; Immunobiology; In silico approaches; Integrated Testing Strategies; Microfabrication; Microfluidics; QSAR; Skin sensitization

Year:  2012        PMID: 24741377      PMCID: PMC3985137          DOI: 10.1007/s12195-011-0189-4

Source DB:  PubMed          Journal:  Cell Mol Bioeng        ISSN: 1865-5025            Impact factor:   2.321


  161 in total

1.  A simple reconstructed human epidermis: preparation of the culture model and utilization in in vitro studies.

Authors:  Y Poumay; F Dupont; S Marcoux; M Leclercq-Smekens; M Hérin; A Coquette
Journal:  Arch Dermatol Res       Date:  2004-09-02       Impact factor: 3.017

2.  The in vitro skin irritation of chemicals: optimisation of the EPISKIN prediction model within the framework of the ECVAM validation process.

Authors:  Jose Cotovio; Marie-Helene Grandidier; Pascal Portes; Roland Roguet; Gilles Rubinstenn
Journal:  Altern Lab Anim       Date:  2005-08       Impact factor: 1.303

Review 3.  The Nrf2-Keap1-ARE toxicity pathway as a cellular sensor for skin sensitizers--functional relevance and a hypothesis on innate reactions to skin sensitizers.

Authors:  Andreas Natsch
Journal:  Toxicol Sci       Date:  2009-09-18       Impact factor: 4.849

4.  Contact allergy to topical corticosteroids--results from the IVDK and epidemiological risk assessment.

Authors:  Wolfgang Uter; Cristiane Menezes de Pádua; Annette Pfahlberg; Katrin Nink; Axel Schnuch; Holger Lessmann
Journal:  J Dtsch Dermatol Ges       Date:  2008-08-28       Impact factor: 5.584

5.  Characterization of the sensitizing potential of chemicals by in vitro analysis of dendritic cell activation and skin penetration.

Authors:  Pierre Aeby; Christoph Wyss; Heinz Beck; Peter Griem; Heike Scheffler; Carsten Goebel
Journal:  J Invest Dermatol       Date:  2004-05       Impact factor: 8.551

6.  Modeling and assaying dioxin-like biological effects for both dioxin-like and certain non-dioxin-like compounds.

Authors:  Jon G Wilkes; Bruce S Hass; Dan A Buzatu; Lisa M Pence; Jeffrey C Archer; Richard D Beger; Laura K Schnackenberg; Mary Kim Halbert; Lisa Jennings; Ralph L Kodell
Journal:  Toxicol Sci       Date:  2007-12-07       Impact factor: 4.849

7.  Development of quantitative structure-activity relationship (QSAR) models to predict the carcinogenic potency of chemicals I. Alternative toxicity measures as an estimator of carcinogenic potency.

Authors:  Raghuraman Venkatapathy; Ching Yi Wang; Robert Mark Bruce; Chandrika Moudgal
Journal:  Toxicol Appl Pharmacol       Date:  2008-10-15       Impact factor: 4.219

8.  Role of TNF-alpha and extracellular ATP in THP-1 cell activation following allergen exposure.

Authors:  Masaaki Miyazawa; Yuichi Ito; Nanae Kosaka; Yuko Nukada; Hitoshi Sakaguchi; Hiroyuki Suzuki; Naohiro Nishiyama
Journal:  J Toxicol Sci       Date:  2008-02       Impact factor: 2.196

9.  Evaluation of a microfluidic based cell culture platform with primary human hepatocytes for the prediction of hepatic clearance in human.

Authors:  P Chao; T Maguire; E Novik; K-C Cheng; M L Yarmush
Journal:  Biochem Pharmacol       Date:  2009-05-20       Impact factor: 5.858

10.  STUDIES ON THE SENSITIZATION OF ANIMALS WITH SIMPLE CHEMICAL COMPOUNDS. II.

Authors:  K Landsteiner; J Jacobs
Journal:  J Exp Med       Date:  1936-09-30       Impact factor: 14.307

View more
  4 in total

Review 1.  Stem cells technology: a powerful tool behind new brain treatments.

Authors:  Lucienne N Duru; Zhenzhen Quan; Talal Jamil Qazi; Hong Qing
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

2.  Microdevice integrating innate and adaptive immune responses associated with antigen presentation by dendritic cells.

Authors:  Bhaskar Mitra; Rohit Jindal; Serom Lee; Dave Xu Dong; Lulu Li; Nripen Sharma; Tim Maguire; Rene Schloss; Martin L Yarmush
Journal:  RSC Adv       Date:  2013-07-05       Impact factor: 3.361

3.  Correlating the structure and reactivity of a contact allergen, DNCB, and its analogs to sensitization potential.

Authors:  Flora Kimani; Seong-Min Kim; Rachel Steinhardt; Aaron P Esser-Kahn
Journal:  Bioorg Med Chem       Date:  2019-05-11       Impact factor: 3.641

Review 4.  Towards a strategic approaches in alternative tests for pesticide safety.

Authors:  Yoonjeong Jang; Ji-Eun Kim; Sang-Hee Jeong; Myung-Haing Cho
Journal:  Toxicol Res       Date:  2014-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.